Detection of elevated AFP combined with hypoechoic nodule or mass is essential in the diagnosis of HCC with 82.6% sensitivity and 70.4% specificity [48], and confirmation of higher cancer risk in DM2 patients encourages special attention in this group [23]. This evidence concerns the gene AFP and hepatocellular carcinoma.